NRx Pharmaceuticals (NRXP) Reschedules Q3 Call

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will reschedule its third quarter and year to date 2024 results conference call to Monday November 18, 2024 at 4:30pm ET, to accommodate any additional corporate news.

A live webcast of the conference call will be available on the Company's website at https://ir.nrxpharma.com/events. Participants that are unable to join the webcast can access the conference call via telephone by dialing domestically +1-800-717-1738 or internationally +1-646-307-1865.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Cytek faces $56M damages award in Beckman Coulter patent case
• Real and RE/MAX Holdings receive court approval for merger